Back to search

SKATTEFUNN-SKATTEFUNN

Health benefits of Lysoveta (LPC bound EPA & DHA) in general healthy population

Alternative title: Health benefits of Lysoveta (LPC bound EPA & DHA) in general healthy population

Source:

Company's project manager:

Not available

Project Number:

339409

Project Period:

2022 - 2023

Organisation:

AKER BIOMARINE ANTARCTIC AS

County:

A key advantage of krill oil is that its omega-3 fatty acids are predominantly bound to phospholipids. Currently, the phospholipid content of our oils range from around 40% to 56%, we have been developing new methods for concentrating specific phospholipid species, such as phosphatidylcholine and lyso-phosphatidylcholine (LPC) and to increase the amount of omega-3 fatty acids bound to these phospholipids. Now we plan to initiate several human studies using this new LPC bound DHA and EPA product (product name: Lysoveta). Throughout this project, we are aiming to document beneficial effect of Lysoveta on cognition performance in elderly population, and improved sperm quality in healthy male population.

Funding scheme:

SKATTEFUNN-SKATTEFUNN

Thematic Areas and Topics

No thematic area or topic related to the project